Company Filing History:
Years Active: 2015-2016
Title: Charina Schmitigal: Innovator in Rare Cell Separation Technologies
Introduction
Charina Schmitigal is a prominent inventor based in San Diego, CA, known for her significant contributions to the field of biotechnology. With a focus on methods for separating rare cells from fluid samples, she has developed innovative techniques that have the potential to advance cancer research and diagnostics. Charina holds a total of 3 patents, showcasing her dedication to innovation in her field.
Latest Patents
Charina's latest patents include groundbreaking methods and compositions for enriching rare cells, such as cancer cells, from biological samples like blood. These methods involve performing at least one debulking step on a blood sample and selectively removing undesirable components to obtain a sample enriched in the rare cells of interest. In some embodiments, magnetic beads coupled to specific binding members are utilized to enhance the separation process. This innovative approach not only improves the efficiency of rare cell isolation but also holds promise for better cancer diagnostics and treatment strategies.
Career Highlights
Charina Schmitigal has made significant strides in her career, particularly through her work at Aviva Biosciences Corporation. Her expertise in biotechnology and her commitment to research have positioned her as a key player in the development of advanced cell separation technologies. Her contributions have been instrumental in pushing the boundaries of what is possible in the field of cancer research.
Collaborations
Charina has collaborated with notable colleagues, including Douglas T. Yamanishi and Paul G. Hujsak. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas, further enhancing the impact of her work.
Conclusion
Charina Schmitigal's innovative work in the field of rare cell separation technologies exemplifies her commitment to advancing medical research. Her patents and collaborations reflect her significant contributions to biotechnology, particularly in cancer diagnostics. As she continues to develop new methods and technologies, her impact on the field is sure to grow.